Daniel S. Wechsler

Hematology | Oncology
2220 N Druid Hills Rd NE
Atlanta, GA 30329

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

PICALM::MLLT10 translocated leukemia.

PICALM::MLLT10 translocated leukemia.

Journal: FEBS letters
Published: August 27, 2025

Successful Resolution of Compartment Syndrome in a Pediatric Patient With B-cell Acute Lymphoblastic Leukemia.

Successful Resolution of Compartment Syndrome in a Pediatric Patient With B-cell Acute Lymphoblastic Leukemia.

Journal: Journal of pediatric hematology/oncology
Published: August 12, 2025

Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML.

Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML.

Journal: Cell reports
Published: January 07, 2025

Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia.

Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia.

Journal: Research square
Published: August 16, 2024

Novel-and Not So Novel-Inhibitors of the Multifunctional CRM1 Protein.

Novel-and Not So Novel-Inhibitors of the Multifunctional CRM1 Protein.

Journal: Oncology reviews
Published: May 03, 2024

Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas.

Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas.

Journal: Nature communications
Published: April 30, 2024

Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1.

Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1.

Journal: Haematologica
Published: January 31, 2024

Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.

Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.

Journal: Genome medicine
Published: May 04, 2023

Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.

Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.

Journal: JCO precision oncology
Published: May 11, 2022

Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.

Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 30, 2021

Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia.

Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia.

Journal: Nature communications
Published: August 20, 2021

Caught in the In-Between: Challenges in Treating Adolescents and Young Adults With Cancer.

Caught in the In-Between: Challenges in Treating Adolescents and Young Adults With Cancer.

Journal: JCO oncology practice
Published: April 29, 2021
Showing 1-12 of 43

Last Updated: 09/26/2026